Your browser is no longer supported. Please, upgrade your browser.
CDXS Codexis, Inc. monthly Stock Chart
Codexis, Inc.
Index- P/E- EPS (ttm)-0.35 Insider Own1.10% Shs Outstand59.06M Perf Week6.74%
Market Cap1.09B Forward P/E- EPS next Y-0.41 Insider Trans-11.00% Shs Float57.32M Perf Month35.08%
Income-20.70M PEG- EPS next Q-0.12 Inst Own91.70% Short Float8.33% Perf Quarter34.20%
Sales66.70M P/S16.32 EPS this Y-1.30% Inst Trans0.47% Short Ratio15.75 Perf Half Y45.03%
Book/sh1.54 P/B12.03 EPS next Y10.90% ROA-14.30% Target Price19.33 Perf Year19.18%
Cash/sh1.22 P/C15.23 EPS next 5Y15.00% ROE-21.20% 52W Range8.43 - 18.87 Perf YTD15.82%
Dividend- P/FCF- EPS past 5Y15.80% ROI-11.90% 52W High-1.85% Beta1.08
Dividend %- Quick Ratio5.00 Sales past 5Y14.20% Gross Margin83.10% 52W Low119.69% ATR0.64
Employees161 Current Ratio5.00 Sales Q/Q-16.00% Oper. Margin-31.20% RSI (14)82.38 Volatility3.57% 4.39%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin-31.10% Rel Volume0.87 Prev Close18.01
ShortableYes LT Debt/Eq0.00 EarningsNov 05 AMC Payout- Avg Volume302.97K Price18.52
Recom1.70 SMA2018.20% SMA5031.08% SMA20049.68% Volume262,162 Change2.83%
Mar-10-20Initiated The Benchmark Company Buy
Jan-17-19Upgrade First Analysis Sec Neutral → Outperform $12 → $19
May-16-18Initiated Stephens Overweight $16
Oct-13-17Reiterated H.C. Wainwright Buy $8 → $8.50
May-31-17Initiated Jefferies Buy $8
Jan-26-17Downgrade First Analysis Sec Overweight → Equal-Weight $5.50
Jan-04-17Upgrade Ladenburg Thalmann Neutral → Buy
Jan-06-16Initiated H.C. Wainwright Buy $6
Nov-24-20 05:02PM  
Nov-09-20 07:00AM  
Nov-07-20 08:38AM  
Nov-05-20 08:30PM  
Oct-29-20 07:00AM  
Sep-08-20 07:00AM  
Aug-11-20 08:33AM  
Aug-06-20 04:05PM  
Jul-30-20 07:00AM  
Jul-28-20 12:33PM  
Jun-23-20 07:00AM  
Jun-22-20 03:06PM  
Jun-16-20 04:05PM  
Jun-14-20 03:50PM  
Jun-01-20 04:05PM  
May-27-20 07:00AM  
May-22-20 07:31PM  
May-11-20 07:00AM  
May-09-20 01:30AM  
May-07-20 04:05PM  
May-06-20 04:05PM  
May-05-20 07:00AM  
Apr-30-20 07:00AM  
Apr-27-20 12:31PM  
Apr-07-20 08:37AM  
Mar-23-20 07:00AM  
Mar-13-20 01:57PM  
Mar-02-20 10:15AM  
Mar-01-20 07:19AM  
Feb-27-20 06:55PM  
Feb-25-20 07:00AM  
Feb-20-20 07:00AM  
Jan-31-20 07:52AM  
Jan-13-20 04:05PM  
Jan-10-20 07:00AM  
Jan-01-20 09:06AM  
Dec-24-19 07:24AM  
Dec-23-19 07:00AM  
Dec-16-19 06:10AM  
Dec-05-19 04:05PM  
Dec-02-19 12:32PM  
Nov-16-19 09:39PM  
Nov-06-19 09:00AM  
Nov-05-19 07:55PM  
Oct-29-19 07:00AM  
Oct-27-19 08:13PM  
Oct-26-19 09:13AM  
Oct-15-19 04:05PM  
Sep-26-19 08:00AM  
Sep-20-19 06:57AM  
Aug-29-19 07:11AM  
Aug-22-19 11:15PM  
Aug-09-19 01:32PM  
Aug-07-19 03:49PM  
Aug-06-19 07:35PM  
Jul-30-19 07:00AM  
Jun-27-19 03:01PM  
Jun-20-19 07:00AM  
Jun-10-19 12:06PM  
May-30-19 07:00AM  
May-16-19 09:34AM  
May-15-19 09:00AM  
May-14-19 04:05PM  
May-10-19 01:51AM  
May-09-19 10:07AM  
May-07-19 10:57AM  
May-06-19 07:25PM  
Apr-30-19 10:54AM  
Apr-29-19 07:00AM  
Apr-19-19 02:09PM  
Apr-05-19 04:05PM  
Mar-22-19 09:41AM  
Mar-14-19 11:15AM  
Mar-07-19 01:25PM  
Mar-05-19 07:00AM  
Mar-02-19 11:48AM  
Mar-01-19 07:45AM  
Feb-27-19 10:18AM  
Feb-26-19 08:14PM  
Feb-25-19 07:00AM  
Feb-23-19 09:13AM  
Feb-19-19 07:00AM  
Feb-14-19 07:00AM  
Feb-06-19 07:00AM  
Codexis, Inc. discovers, develops, and sells protein catalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KELLEY BERNARD JDirectorOct 21Sale14.002,50035,007211,136Oct 23 04:04 PM
Dorgan Byron LDirectorOct 09Option Exercise10.6325,000265,750187,790Oct 13 04:04 PM
Dorgan Byron LDirectorOct 09Sale13.5425,000338,528162,790Oct 13 04:04 PM
Dorgan Byron LDirectorOct 08Option Exercise10.6325,000265,750187,790Oct 13 04:04 PM
Dorgan Byron LDirectorOct 08Sale13.4925,000337,315162,790Oct 13 04:04 PM
WOLF DENNIS PDirectorSep 24Sale11.6810,000116,84561,129Sep 28 04:03 PM
KELLEY BERNARD JDirectorJul 21Sale12.792,50031,965213,636Jul 23 04:16 PM
WOLF DENNIS PDirectorJun 25Sale10.9710,000109,69471,129Jun 26 04:18 PM
BARUCH THOMAS RDirectorJun 12Sale10.614,94752,46433,093Jun 16 04:03 PM
KELLEY BERNARD JDirectorApr 21Sale10.582,50026,450207,184Apr 23 04:07 PM
BARUCH THOMAS RDirectorApr 02Sale10.527,50078,86638,040Apr 03 04:07 PM
BARUCH THOMAS RDirectorApr 01Sale10.887,50081,57645,540Apr 03 04:07 PM
WOLF DENNIS PDirectorMar 25Sale10.3810,000103,78572,177Mar 27 04:42 PM
Dorgan Byron LDirectorFeb 21Sale14.0216,702234,192153,838Feb 25 06:02 PM
KELLEY BERNARD JDirectorJan 21Sale18.002,50045,000209,684Jan 22 05:20 PM
BARUCH THOMAS RDirectorJan 16Sale18.6110,000186,09053,040Jan 17 04:18 PM
BARUCH THOMAS RDirectorJan 15Sale18.6810,000186,81663,040Jan 17 04:18 PM
WOLF DENNIS PDirectorDec 19Option Exercise3.6220,00072,400102,177Dec 20 05:07 PM
WOLF DENNIS PDirectorDec 19Sale16.2220,000324,38482,177Dec 20 05:07 PM
Dorgan Byron LDirectorDec 12Sale15.6425,000390,973170,540Dec 13 04:10 PM
BARUCH THOMAS RDirectorDec 11Sale15.5917,500272,89273,040Dec 12 04:10 PM
BARUCH THOMAS RDirectorDec 10Sale15.6117,500273,23690,540Dec 12 04:10 PM